Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think both can do ok. NCYT can't keep up with demand and their test is limited but if it helps I'm all for it.
This baby is a different kettle of fish... 10,000 tests per hour potential and 2nd test that can be carried out onsite..
It'll take a few months here to get approval and there will be ups and downs but I'll just sit and watch this rise over time.
GLA.
Please don't compare NCYT to GDR.........NCYT over bought and Mcap is too big.
People ramping NCYT will be here to deramp.
This was way oversold even before the covid 19 test RNS. Now it just needs to re-rate to a more reasonable level. Anyone who thinks this company is overvalued at £10m in this current climate is deluding themselves to get a better entry. Games will obvs be played like with all shares but if you want to get in, just get in and hold long.
However the numbers are crunched this looks cheap to me... £10m Mcap is tiny, even at £20m it would be a bargain.
Last DOD order cumulative look to be ca. £3m, new order for 500 units and associated assays should be significantly larger, say $5m. AIHL assay worth up to £3m per annum in the UK, now on market. HCV potential larger but say they are the same its looks to have somewhere in the region of £6m-£7m per annum lined up in products now on market. At 5x multiple this would be £35m mc or £1 per share. This is without COVID or TB which is their other assay, both even larger markets. Potential for £2-£3 per share when on market status announced. imo
You forget the tiny cap compared to NCYT! Obvious you are looking to get back in much cheaper and there in lies your understandable frustration! Good luck on your re-entry if you are able to!
Not bitter at only lost a few pennies compared to thousands made at NCYT.
In 5 weeks yes COVID19 will still be here but can you go from standing start and catch competition who are months ahead and generating massive sales with approved 100% accurate tests plus god knows what CHINA can produce test wise in 5 weeks.
Would love to invest here but just cannot see value ( So looking like a classic Pump and Dump ) until they announce some solid sales or order numbers which are still weeks off. Some criticise NCYT but numbers Sales/Orders they are producing are astounding.
Can anybody produce any figures Sales/Orders to justify sp?
Oh dear dingdangdidgerydoo!! Sounds like you were done on the spike without lube. Again peeps... hold tight and be patient. Spikes are short lived here as GDR has a bright outlook. 10,000 tests per hour. Results at point of care and no need to send back to a lab. DOD has just signed up too! PATIENCE is the key here. Next business update will be here sooner than you think. HOLD HOLD HOLD.
NCYT is more than 13x the Market Cap of this. The SP was at ~21p earlier this year.
After such an announcement, I'd say there's a lot more to come. NCYT requires a lab, this test is point of care. You really think covid-19 is going away in 5 weeks? I really hope it does but I severely doubt it. 10,000 tests per hour. PER HOUR.
Bitterness comes to mind lol missed the boat have we lol!
You’re only deramping because you sold your £500 worth that you bought on Friday...
Got caught on the last spike here.
Have re-read all the RNS this SP increase looks overcooked and over-ramped.
No Sales data yet ( unlike NCYT )
No approval of Tests ( unlike NCYT )
5 weeks away from test even been ready. Competitors will increase and take all mkt share.
No guarantee of any sales.
5 weeks time is a lifetime - More tests will have been provided be competitors by the day!